Sublingual Immunotherapy a Potential Treatment for Allergic Rhinitis

Sublingual immunotherapy (SLIT) is a common treatment for allergic rhinitis in Europe, and allergists in the United States are becoming increasingly interested in this form of therapy.

However, several challenges need to be addressed before SLIT is readily available to the public, according to experts interviewed for this article.

For example, efficacy compared to subcutaneous immunotherapy (SCIT) and appropriate dosing need to be established, and a sublingual extract has yet to be approved by the Food and Drug Administration (FDA).

Pages: First |1 | 2 | 3 | ... | Next → | Last | Single Page